The Wall Street Journal and Reuters report it's unclear how big of an investment the hedge fund has made in the maker of Tylenol ... changes to boost its stock price, while Reuters pointed ...

Kenvue reports Q3 sales of $3.89 billion, slightly missing estimates. Strong growth in Essential Health offsets declines in ...

Price Action: Kenvue Inc.’s stock closed at $21.72 on Friday, up 1.26% with a gain of $0.27. Year to date, the stock has ...

(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, Listerine, and Tylenol, and which went public last year, two people familiar with ...